S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
The former chairman of the state-owned Bank of Beijing is being investigated for alleged corruption
Trader Joe's chicken soup dumplings recalled for possibly containing permanent marker plastic
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Stock market today: World markets are mixed and Japan's Nikkei tops 40,000, on eve of China congress
China seeks ways to revive slowing economy and salvage property market as annual congress convenes
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Arkhouse and Brigade up Macy's takeover offer to $6.6 billion following rejection of previous deal
OPEC+ production cuts deepen with extensions from Saudi Arabia, Russia and other oil giants
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
The former chairman of the state-owned Bank of Beijing is being investigated for alleged corruption
Trader Joe's chicken soup dumplings recalled for possibly containing permanent marker plastic
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Stock market today: World markets are mixed and Japan's Nikkei tops 40,000, on eve of China congress
China seeks ways to revive slowing economy and salvage property market as annual congress convenes
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Arkhouse and Brigade up Macy's takeover offer to $6.6 billion following rejection of previous deal
OPEC+ production cuts deepen with extensions from Saudi Arabia, Russia and other oil giants
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
The former chairman of the state-owned Bank of Beijing is being investigated for alleged corruption
Trader Joe's chicken soup dumplings recalled for possibly containing permanent marker plastic
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Stock market today: World markets are mixed and Japan's Nikkei tops 40,000, on eve of China congress
China seeks ways to revive slowing economy and salvage property market as annual congress convenes
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Arkhouse and Brigade up Macy's takeover offer to $6.6 billion following rejection of previous deal
OPEC+ production cuts deepen with extensions from Saudi Arabia, Russia and other oil giants
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
The former chairman of the state-owned Bank of Beijing is being investigated for alleged corruption
Trader Joe's chicken soup dumplings recalled for possibly containing permanent marker plastic
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Stock market today: World markets are mixed and Japan's Nikkei tops 40,000, on eve of China congress
China seeks ways to revive slowing economy and salvage property market as annual congress convenes
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Arkhouse and Brigade up Macy's takeover offer to $6.6 billion following rejection of previous deal
OPEC+ production cuts deepen with extensions from Saudi Arabia, Russia and other oil giants

Cyclo Therapeutics (CYTH) News Today

$1.61
+0.01 (+0.63%)
(As of 03/1/2024 08:51 PM ET)
SourceHeadline
finance.yahoo.com logoCyclo Therapeutics, Inc. (CYTH)
finance.yahoo.com - February 2 at 9:30 AM
markets.businessinsider.com logoCyclo Therapeutics Gets Notice Of Allowance For Patent Regarding Treatment Of Alzheimer's Disease
markets.businessinsider.com - January 29 at 12:14 PM
finance.yahoo.com logoCyclo Therapeutics Announces Allowance of Patent Application for Treatment of Alzheimer’s Disease from the U.S. Patent and Trademark Office
finance.yahoo.com - January 29 at 12:14 PM
morningstar.com logoCyclo Therapeutics Inc CYTH
morningstar.com - January 3 at 10:30 PM
msn.com logoCytosorbents, Cyclo Therapeutics among healthcare movers
msn.com - December 28 at 2:48 PM
finance.yahoo.com logoCyclo Therapeutics Announces Positive Outcome from Type C Meeting with the U.S. FDA Discussing Trappsol® Cyclo™ Clinical Program for the Treatment of Niemann-Pick Disease Type C1
finance.yahoo.com - December 18 at 4:09 PM
finance.yahoo.com logoRafael Holdings Reports First Quarter Fiscal 2024 Financial Results
finance.yahoo.com - December 14 at 6:19 PM
businesswire.com logoAPPLIED MOLECULAR INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Applied ...
businesswire.com - November 29 at 3:13 PM
finance.yahoo.com logoCyclo Therapeutics to Present at the 20th Annual WORLDSymposium™ 2024
finance.yahoo.com - November 21 at 10:04 AM
msn.com logoCyclo Therapeutics reports Q3 results
msn.com - November 15 at 1:19 PM
finance.yahoo.com logoCyclo Therapeutics Reports Third Quarter 2023 Financial Results
finance.yahoo.com - November 15 at 8:19 AM
seekingalpha.com logoWISH, REAL and PIXY among mid-day movers
seekingalpha.com - November 10 at 8:24 PM
finance.yahoo.com logoSeveral Insiders Invested In Cyclo Therapeutics Flagging Positive News
finance.yahoo.com - November 2 at 10:15 AM
finance.yahoo.com logoRafael Holdings Reports Fourth Quarter and Full Year Fiscal 2023 Financial Results
finance.yahoo.com - October 30 at 6:00 PM
finance.yahoo.com logoCyclo Therapeutics Announces Early Exercise of Warrants by Board Members, Management and a Significant Shareholder Resulting in Cash Proceeds of $2.4 Million
finance.yahoo.com - October 23 at 1:02 PM
finance.yahoo.com logoCyclo Therapeutics to Present at 8th Annual Dawson James Conference
finance.yahoo.com - October 5 at 12:45 PM
tmcnet.com logoCYTH Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Cyclo Therapeutics, Inc. Is Fair to Shareholders
tmcnet.com - September 21 at 1:08 PM
finance.yahoo.com logoCyclo Therapeutics, Inc. and Applied Molecular Transport Inc. Enter into a Definitive Merger Agreement
finance.yahoo.com - September 21 at 8:07 AM
finance.yahoo.com logoCyclo Therapeutics Reports Second Quarter 2023 Financial Results
finance.yahoo.com - August 15 at 6:55 PM
benzinga.com logoCyclo Therapeutics And This Other Penny Stock Insiders Are Buying
benzinga.com - August 3 at 12:24 PM
benzinga.com logoCyclo Therapeutics Announces Allowance of Patent from European Patent Office for Trappsol® Cyclo™ for Alzheimer's Disease
benzinga.com - June 12 at 6:48 PM
finance.yahoo.com logoPositive Signs As Multiple Insiders Buy Cyclo Therapeutics Stock
finance.yahoo.com - May 22 at 10:43 AM
finance.yahoo.com logoCyclo Therapeutics Provides Business Update and Reports First Quarter 2023 Financial Results
finance.yahoo.com - May 15 at 8:24 AM
finance.yahoo.com logoCyclo Therapeutics Announces Closing of Strategic Investment Through a $2.1 Million Private Placement from Rafael Holdings, Inc. (NYSE:RFL)
finance.yahoo.com - May 2 at 8:58 AM
benzinga.com logoCyclo Therapeutics Stock (NASDAQ:CYTH), Guidance and Forecast
benzinga.com - April 28 at 2:04 AM
finance.yahoo.com logoCyclo Therapeutics Announces Closing of $1.3 Million Private Placement Priced At-The-Market Under Nasdaq Rules
finance.yahoo.com - April 21 at 12:17 PM
msn.com logoCyclo Therapeutics's Return On Capital Employed Insights
msn.com - March 21 at 2:33 PM
marketwatch.com logoCyclo Therapeutics in Talks About Possible Combination
marketwatch.com - March 20 at 7:03 PM
finance.yahoo.com logoCyclo Therapeutics Provides Business Update and Reports Full Year 2022 Financial Results
finance.yahoo.com - March 20 at 8:58 AM
seekingalpha.com logoCYTH Cyclo Therapeutics, Inc.
seekingalpha.com - March 15 at 11:22 PM
benzinga.com logoCyclo Therapeutics Chief Operating Officer Awarded $44K Worth of Stock Options
benzinga.com - March 10 at 5:24 PM
benzinga.com logoCyclo Therapeutics Chief Regulatory Officer Awarded $44K Worth of Stock Options
benzinga.com - March 10 at 12:23 PM
benzinga.com logoCyclo Therapeutics Board Member Awarded $3K Worth of Stock Options
benzinga.com - March 10 at 12:23 PM
barrons.com logoCyclo Therapeutics Announces First Patient Dosed in Phase 2b Study of Trappsol(R) Cyclo(TM) for the Treatment of Early Alzheimer's Disease
barrons.com - January 11 at 11:03 PM
finance.yahoo.com logoCyclo Therapeutics Provides Clinical Program Update and Highlights Recent Achievements
finance.yahoo.com - January 11 at 1:03 PM
finance.yahoo.com logoCyclo Therapeutics to Present at the Virtual Investor 2023 Companies to Watch Event
finance.yahoo.com - January 10 at 10:11 AM
benzinga.com logoCyclo Therapeutics Announces First Patient Dosed in Phase 2b Study of Trappsol® Cyclo™ for the Treatment of Early Alzheimer's Disease
benzinga.com - January 9 at 1:16 PM
finance.yahoo.com logoCyclo Therapeutics Announces First Patient Dosed in Phase 2b Study of Trappsol® Cyclo™ for the Treatment of Early Alzheimer’s Disease
finance.yahoo.com - January 9 at 8:15 AM
finance.yahoo.com logoCyclo Therapeutics Announces Closing of $4.2 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
finance.yahoo.com - January 4 at 4:19 PM
finance.yahoo.com logoCyclo Therapeutics Announces Abstract Accepted for Poster Presentation at the Society for Inherited Metabolic Disorders (SIMD) 44th Annual Meeting
finance.yahoo.com - January 4 at 11:18 AM
msn.com logoCyclo Therapeutics announces direct offering for up to $4.2M
msn.com - December 30 at 10:05 AM
finance.yahoo.com logoCyclo Therapeutics Announces $4.2 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
finance.yahoo.com - December 30 at 10:05 AM
msn.com logoWhy Cracker Barrel Shares Are Trading Lower By Around 13%? Here Are 42 Stocks Moving In Friday's Mid-Day Session
msn.com - December 2 at 7:28 PM
finance.yahoo.com logoCyclo Therapeutics Reports Third Quarter 2022 Financial Results and Highlights Recent Achievements
finance.yahoo.com - November 11 at 10:18 AM
finance.yahoo.com logoCyclo Therapeutics Announces Publication of Phase 1 Data for Trappsol® Cyclo™ for the Treatment of Niemann-Pick Disease Type C1 (NPC1)
finance.yahoo.com - October 18 at 8:19 AM
stockhouse.com logoCyclo Therapeutics Commences Phase 2b Study of Trappsol® Cyclo(TM) for the Treatment of Early Alzheimer's Disease
stockhouse.com - October 6 at 6:36 PM
barrons.com logoCyclo Therapeutics Commences Phase 2b Study of Trappsol(R) Cyclo(TM) for the Treatment of Early Alzheimer's Disease
barrons.com - October 6 at 1:35 PM
finance.yahoo.com logoCyclo Therapeutics Commences Phase 2b Study of Trappsol® Cyclo™ for the Treatment of Early Alzheimer’s Disease
finance.yahoo.com - October 4 at 8:49 AM
marketwatch.com logoCyclo Therapeutics Up 21%; Company 'Pleased' With Progress on Drug Programs
marketwatch.com - September 30 at 1:04 AM
finance.yahoo.com logoCyclo Therapeutics Provides Business Update
finance.yahoo.com - September 28 at 6:42 PM
Get Cyclo Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for CYTH and its competitors with MarketBeat's FREE daily newsletter.



CYTH Media Mentions By Week

CYTH Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CYTH
News Sentiment

1.44

0.65

Average
Medical
News Sentiment

CYTH News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CYTH Articles
This Week

2

0

CYTH Articles
Average Week

Get Cyclo Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for CYTH and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:CYTH) was last updated on 3/4/2024 by MarketBeat.com Staff